{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:56:57Z","timestamp":1784865417964,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003818"],"award-info":[{"award-number":["82003818"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151525"],"award-info":[{"award-number":["82151525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-CoV19-001"],"award-info":[{"award-number":["2022-I2M-CoV19-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02673-2","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:01:50Z","timestamp":1741082510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2"],"prefix":"10.1186","volume":"22","author":[{"given":"Mengyuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"crossref","unstructured":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536\u2013544.","DOI":"10.1038\/s41564-020-0695-z"},{"key":"2673_CR2","doi-asserted-by":"publisher","first-page":"1232772","DOI":"10.3389\/fcimb.2023.1232772","volume":"13","author":"AM Khalil","year":"2023","unstructured":"Khalil AM, Martinez-Sobrido L, Mostafa A. Zoonosis and zooanthroponosis of emerging respiratory viruses. Front Cell Infect Microbiol. 2023;13:1232772.","journal-title":"Front Cell Infect Microbiol"},{"key":"2673_CR3","doi-asserted-by":"publisher","first-page":"RP91745","DOI":"10.7554\/eLife.91745","volume":"13","author":"R Maestri","year":"2024","unstructured":"Maestri R, Perez-Lamarque B, Zhukova A, Morlon H. Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses. Elife. 2024;13:RP91745.","journal-title":"Elife"},{"key":"2673_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/cid\/ciac180","volume":"76","author":"LD Saravolatz","year":"2023","unstructured":"Saravolatz LD, Depcinski S, Sharma M. Molnupiravir and Nirmatrelvir-Ritonavir: oral coronavirus disease 2019 antiviral drugs. Clin Infect Dis. 2023;76:165\u201371.","journal-title":"Clin Infect Dis"},{"key":"2673_CR5","doi-asserted-by":"publisher","first-page":"20825","DOI":"10.1038\/s41598-024-71588-9","volume":"14","author":"M Balik","year":"2024","unstructured":"Balik M, Waldauf P, Jurisinova I, Svobodova E, Diblickova M, Tencer T, Zavora J, Smela G, Kupidlovska L, Adamkova V, et al. SARS-CoV-2 viral load is linked to remdesivir efficacy in severe Covid-19 admitted to intensive care. Sci Rep. 2024;14:20825.","journal-title":"Sci Rep"},{"key":"2673_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41392-021-00835-6","volume":"6","author":"JL Zhang","year":"2021","unstructured":"Zhang JL, Li YH, Wang LL, Liu HQ, Lu SY, Liu Y, Li K, Liu B, Li SY, Shao FM, et al. Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients. Signal Transduct Target Ther. 2021;6:414.","journal-title":"Signal Transduct Target Ther"},{"key":"2673_CR7","doi-asserted-by":"publisher","DOI":"10.2196\/45513","volume":"10","author":"SP Harrigan","year":"2024","unstructured":"Harrigan SP, Vel\u00e1squez Garc\u00eda HA, Abdia Y, Wilton J, Prystajecky N, Tyson J, Fjell C, Hoang L, Kwong JC, Mishra S, et al. The clinical severity of COVID-19 variants of concern: retrospective population-based analysis. JMIR Public Health Surveill. 2024;10: e45513.","journal-title":"JMIR Public Health Surveill"},{"key":"2673_CR8","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e270","volume":"39","author":"H Jung","year":"2024","unstructured":"Jung H, Park JY, Yoon D, Kang DY, Jung J, Kim JH, Shin JY. Patient-reported adverse events among elderly patients receiving novel oral COVID-19 antivirals: a nationwide sampled survey in Korea. J Korean Med Sci. 2024;39: e270.","journal-title":"J Korean Med Sci"},{"key":"2673_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40588-024-00229-6","volume":"11","author":"UM Lopez","year":"2024","unstructured":"Lopez UM, Hasan MM, Havranek B, Islam SM. SARS-CoV-2 resistance to small molecule inhibitors. Curr Clin Microbiol Rep. 2024;11:127\u201339.","journal-title":"Curr Clin Microbiol Rep"},{"key":"2673_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.FUNK-0009-2016","volume":"4","author":"GF Bills","year":"2016","unstructured":"Bills GF, Gloer JB. Biologically active secondary metabolites from the fungi. Microbiol Spectr. 2016;4:10.","journal-title":"Microbiol Spectr"},{"key":"2673_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/164_2019_331","volume":"261","author":"B T\u00f6nshoff","year":"2020","unstructured":"T\u00f6nshoff B. Immunosuppressants in organ transplantation. Handb Exp Pharmacol. 2020;261:441\u201369.","journal-title":"Handb Exp Pharmacol"},{"key":"2673_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12016-023-08963-3","volume":"65","author":"R Bhat","year":"2023","unstructured":"Bhat R, Tonutti A, Timilsina S, Selmi C, Gershwin ME. Perspectives on mycophenolate mofetil in the management of autoimmunity. Clin Rev Allergy Immunol. 2023;65:86\u2013100.","journal-title":"Clin Rev Allergy Immunol"},{"key":"2673_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.32131","volume":"7","author":"Y You","year":"2024","unstructured":"You Y, Zhou Z, Wang F, Li J, Liu H, Cheng X, Su Y, Chen X, Zheng H, Sun Y, et al. Mycophenolate mofetil and new-onset systemic lupus erythematosus: a randomized clinical trial. JAMA Netw Open. 2024;7: e2432131.","journal-title":"JAMA Netw Open"},{"key":"2673_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1399-0012.1996.tb00651.x","volume":"10","author":"AC Allison","year":"1996","unstructured":"Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transpl. 1996;10:77\u201384.","journal-title":"Clin Transpl"},{"key":"2673_CR15","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/00007890-200003150-00038","volume":"69","author":"Y Qiu","year":"2000","unstructured":"Qiu Y, Fairbanks LD, R\u00fcckermann K, Hawrlowicz CM, Richards DF, Kirschbaum B, Simmonds HA. Mycophenolic acid-induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen-stimulated primary human T-lymphocytes. Transplantation. 2000;69:890\u20137.","journal-title":"Transplantation"},{"key":"2673_CR16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/v12091041","volume":"12","author":"D Morales Vasquez","year":"2020","unstructured":"Morales Vasquez D, Park JG, \u00c1vila-P\u00e9rez G, Nogales A, de la Torre JC, Almazan F, Martinez-Sobrido L. Identification of inhibitors of ZIKV replication. Viruses. 2020;12:1041.","journal-title":"Viruses"},{"key":"2673_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2180-3-25","volume":"3","author":"E Padalko","year":"2003","unstructured":"Padalko E, Verbeken E, Matthys P, Aerts JL, De Clercq E, Neyts J. Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice. BMC Microbiol. 2003;3:25.","journal-title":"BMC Microbiol"},{"key":"2673_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00566-23","volume":"11","author":"T Hishiki","year":"2023","unstructured":"Hishiki T, Morita T, Akazawa D, Ohashi H, Park ES, Kataoka M, Mifune J, Shionoya K, Tsuchimoto K, Ojima S, et al. Identification of IMP dehydrogenase as a potential target for anti-Mpox virus agents. Microbiol Spectr. 2023;11: e0056623.","journal-title":"Microbiol Spectr"},{"key":"2673_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1099\/vir.0.061911-0","volume":"95","author":"BJ Hart","year":"2014","unstructured":"Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG, Frieman MB, Holbrook MR, Jahrling PB, Hensley L. Interferon-\u03b2 and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol. 2014;95:571\u20137.","journal-title":"J Gen Virol"},{"key":"2673_CR20","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1099\/vir.0.81655-0","volume":"87","author":"R Takhampunya","year":"2006","unstructured":"Takhampunya R, Ubol S, Houng HS, Cameron CE, Padmanabhan R. Inhibition of dengue virus replication by mycophenolic acid and ribavirin. J Gen Virol. 2006;87:1947\u201352.","journal-title":"J Gen Virol"},{"key":"2673_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.02149-19","volume":"94","author":"JG Park","year":"2020","unstructured":"Park JG, \u00c1vila-P\u00e9rez G, Nogales A, Blanco-Lobo P, de la Torre JC, Mart\u00ednez-Sobrido L. Identification and characterization of novel compounds with broad-spectrum antiviral activity against influenza A and B viruses. J Virol. 2020;94:10.","journal-title":"J Virol"},{"key":"2673_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11259-018-9733-1","volume":"42","author":"QY Chang","year":"2018","unstructured":"Chang QY, Guo FC, Li XR, Zhou JH, Cai X, Pan Q, Ma XX. The IMPDH inhibitors, ribavirin and mycophenolic acid, inhibit peste des petits ruminants virus infection. Vet Res Commun. 2018;42:309\u201313.","journal-title":"Vet Res Commun"},{"key":"2673_CR23","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/hep.25562","volume":"55","author":"Q Pan","year":"2012","unstructured":"Pan Q, de Ruiter PE, Metselaar HJ, Kwekkeboom J, de Jonge J, Tilanus HW, Janssen HL, van der Laan LJ. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo. Hepatology. 2012;55:1673\u201383.","journal-title":"Hepatology"},{"key":"2673_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103762","volume":"137","author":"NR Manchala","year":"2019","unstructured":"Manchala NR, Dungdung R, Trivedi P, Unniyampurath U, Pilankatta R. Mycophenolic acid (MPA) modulates host cellular autophagy progression in sub genomic dengue virus-2 replicon cells. Microb Pathog. 2019;137: 103762.","journal-title":"Microb Pathog"},{"key":"2673_CR25","doi-asserted-by":"publisher","first-page":"44039","DOI":"10.1038\/srep44039","volume":"7","author":"S Fang","year":"2017","unstructured":"Fang S, Su J, Liang B, Li X, Li Y, Jiang J, Huang J, Zhou B, Ning C, Li J, et al. Suppression of autophagy by mycophenolic acid contributes to inhibition of HCV replication in human hepatoma cells. Sci Rep. 2017;7:44039.","journal-title":"Sci Rep"},{"key":"2673_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/1348-0421.12828","volume":"64","author":"F Kato","year":"2020","unstructured":"Kato F, Matsuyama S, Kawase M, Hishiki T, Katoh H, Takeda M. Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2. Microbiol Immunol. 2020;64:635\u20139.","journal-title":"Microbiol Immunol"},{"key":"2673_CR27","first-page":"100158","volume":"3","author":"R Volle","year":"2022","unstructured":"Volle R, Murer L, Petkidis A, Andriasyan V, Savi A, Bircher C, Meili N, Fischer L, Sequeira DP, Mark DK, et al. Methylene blue, Mycophenolic acid, Posaconazole, and Niclosamide inhibit SARS-CoV-2 Omicron variant BA.1 infection of human airway epithelial organoids. Curr Res Microb Sci. 2022;3:100158.","journal-title":"Curr Res Microb Sci"},{"key":"2673_CR28","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.apsb.2024.02.023","volume":"14","author":"H Li","year":"2024","unstructured":"Li H, Li J, Li J, Li H, Wang X, Jiang J, Lei L, Sun H, Tang M, Dong B, et al. Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed -1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element. Acta Pharm Sin B. 2024;14:2567\u201380.","journal-title":"Acta Pharm Sin B"},{"issue":"Suppl 1","key":"2673_CR29","first-page":"E26","volume":"54","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhan Y, Xu R, Shao R, Jiang J, Wang Z. Src mediates extracellular signal-regulated kinase 1\/2 activation and autophagic cell death induced by cardiac glycosides in human non-small cell lung cancer cell lines. Mol Carcinog. 2015;54(Suppl 1):E26-34.","journal-title":"Mol Carcinog"},{"key":"2673_CR30","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.apsb.2021.02.024","volume":"11","author":"H Yan","year":"2021","unstructured":"Yan H, Sun J, Wang K, Wang H, Wu S, Bao L, He W, Wang D, Zhu A, Zhang T, et al. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2. Acta Pharm Sin B. 2021;11:2850\u20138.","journal-title":"Acta Pharm Sin B"},{"key":"2673_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.00562-20","volume":"94","author":"X Zhao","year":"2020","unstructured":"Zhao X, Zheng S, Chen D, Zheng M, Li X, Li G, Lin H, Chang J, Zeng H, Guo JT. LY6E restricts entry of human coronaviruses, including currently pandemic SARS-CoV-2. J Virol. 2020;94:10.","journal-title":"J Virol"},{"key":"2673_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints12. Am J Epidemiol. 1938;27:493\u20137.","journal-title":"Am J Epidemiol"},{"key":"2673_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135201","volume":"279","author":"YA El-Maradny","year":"2024","unstructured":"El-Maradny YA, Badawy MA, Mohamed KI, Ragab RF, Moharm HM, Abdallah NA, Elgammal EM, Rubio-Casillas A, Uversky VN, Redwan EM. Unraveling the role of the nucleocapsid protein in SARS-CoV-2 pathogenesis: From viral life cycle to vaccine development. Int J Biol Macromol. 2024;279: 135201.","journal-title":"Int J Biol Macromol"},{"key":"2673_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.antiviral.2006.10.003","volume":"73","author":"C Ying","year":"2007","unstructured":"Ying C, Colonno R, De Clercq E, Neyts J. Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir. Antiviral Res. 2007;73:192\u20136.","journal-title":"Antiviral Res"},{"key":"2673_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1099\/vir.0.059014-0","volume":"95","author":"X Yang","year":"2014","unstructured":"Yang X, Chen X, Bian G, Tu J, Xing Y, Wang Y, Chen Z. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. J Gen Virol. 2014;95:614\u201326.","journal-title":"J Gen Virol"},{"key":"2673_CR36","doi-asserted-by":"crossref","unstructured":"Jorda A, Ensle D, Eser H, Gl\u00f6tzl F, Riedl B, Szell M, Valipour A, Zoufaly A, Wenisch C, Haider D, et al. Real-world effectiveness of nirmatrelvir-ritonavir and molnupiravir in non-hospitalized adults with COVID-19: a population-based, retrospective cohort study. Clin Microbiol Infect. 2024.","DOI":"10.1016\/j.cmi.2024.10.026"},{"key":"2673_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2006.03.001","volume":"71","author":"DL Barnard","year":"2006","unstructured":"Barnard DL, Day CW, Bailey K, Heiner M, Montgomery R, Lauridsen L, Winslow S, Hoopes J, Li JK, Lee J, et al. Enhancement of the infectivity of SARS-CoV in BALB\/c mice by IMP dehydrogenase inhibitors, including ribavirin. Antiviral Res. 2006;71:53\u201363.","journal-title":"Antiviral Res"},{"key":"2673_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/md22050190","volume":"22","author":"Z Wang","year":"2024","unstructured":"Wang Z, Sun L, Zhao H, Sow MD, Zhang Y, Wang W. Inhibition effects and mechanisms of marine compound mycophenolic acid methyl ester against influenza A virus. Mar Drugs. 2024;22:190.","journal-title":"Mar Drugs"},{"key":"2673_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.acc.2016.04.001","volume":"76","author":"A Dasgupta","year":"2016","unstructured":"Dasgupta A. Therapeutic drug monitoring of mycophenolic acid. Adv Clin Chem. 2016;76:165\u201384.","journal-title":"Adv Clin Chem"},{"key":"2673_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15471","volume":"38","author":"K Doki","year":"2024","unstructured":"Doki K, Yoshida K, Usui J, Takahashi K, Oda T, Yamagata K, Homma M. External validation of a limited sampling strategy for the estimation of mycophenolic acid exposure between different assay methods: PETINIA and HPLC methods. Clin Transpl. 2024;38: e15471.","journal-title":"Clin Transpl"},{"key":"2673_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.116451","volume":"251","author":"R Liu","year":"2024","unstructured":"Liu R, Wu Q, Wu C, Qu Y, Fang Y, De J, Fan R, Song W. Metabolic signatures of metabolites of the purine degradation pathway in human plasma using HILIC UHPLC-HRMS. J Pharm Biomed Anal. 2024;251: 116451.","journal-title":"J Pharm Biomed Anal"},{"key":"2673_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2020.101357","volume":"65","author":"C Xiong","year":"2021","unstructured":"Xiong C, Du Z, Zhu Y, Xue M, Jiang Y, Zhong Y, Jiang L, Chen H, Shi M. Mycophenolate mofetil preconditioning protects mouse liver against ischemia\/reperfusion injury in wild type and toll-like receptor 4 knockout mice. Transpl Immunol. 2021;65: 101357.","journal-title":"Transpl Immunol"},{"key":"2673_CR43","doi-asserted-by":"publisher","first-page":"2301242","DOI":"10.1080\/21505594.2023.2301242","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Pu F, Yang X, Feng X, Zhang J, Duan K, Nian X, Ma Z, Ma XX, Yang XM. Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability. Virulence. 2024;15:2301242.","journal-title":"Virulence"},{"key":"2673_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107116","volume":"63","author":"M Carretero-Ledesma","year":"2024","unstructured":"Carretero-Ledesma M, Aguilar-Guisado M, Berastegui-Cabrera J, Balsera-Manzanero M, Pach\u00f3n J, Cordero E, S\u00e1nchez-C\u00e9spedes J. Antiviral activity of immunosuppressors alone and in combination against human adenovirus and cytomegalovirus. Int J Antimicrob Agents. 2024;63: 107116.","journal-title":"Int J Antimicrob Agents"},{"key":"2673_CR45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ueg2.12417","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li P, Lavrijsen M, Rottier RJ, den Hoed CM, Bruno MJ, Kamar N, Peppelenbosch MP, de Vries AC, Pan Q. Immunosuppressants exert differential effects on pan-coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir. United Eur Gastroenterol J. 2023;11:431\u201347.","journal-title":"United Eur Gastroenterol J"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02673-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:01:57Z","timestamp":1741082517000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02673-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02673-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to the publication of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interests.The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal and human rights statement"}}],"article-number":"56"}}